Symbol="AXSM"
AssetType="Common Stock"
Name="Axsome Therapeutics Inc"
Description="Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York."
CIK="1579428"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="22 CORTLANDT STREET, 16TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3196318000"
EBITDA="-159526384"
PERatio="None"
PEGRatio="0"
BookValue="5.97"
DividendPerShare="0"
DividendYield="0"
EPS="-3.81"
RevenuePerShareTTM="4.234"
ProfitMargin="-1.011"
OperatingMarginTTM="-0.888"
ReturnOnAssetsTTM="-0.256"
ReturnOnEquityTTM="-1.255"
RevenueTTM="182493000"
GrossProfitTTM="45939500"
DilutedEPSTTM="-3.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.295"
AnalystTargetPrice="111.9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="134.76"
PriceToBookRatio="20.66"
EVToRevenue="121.47"
EVToEBITDA="-20.98"
Beta="1.878"
num_52WeekHigh="91.29"
num_52WeekLow="38.87"
num_50DayMovingAverage="76.06"
num_200DayMovingAverage="69.16"
SharesOutstanding="46573200"
DividendDate="None"
ExDividendDate="None"
symbol="AXSM"
open="69.28"
high="72.43"
low="67.52"
price="71.65"
volume="714607.00"
latest_trading_day="2023-08-14"
previous_close="69.60"
change="2.05"
change_percent="2.9454%"
aroon_positive_momentum_days="72"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="72"
Volume_recent_avg="871680"
Change_recent_avg="-0.02"
Delta_recent_avg="3.16"
Variance_recent_avg="1.58"
Change_ratio_recent_avg="-0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="72"
Aroon_momentum_negative="28"
image_negative_thumbnail_id_1="175"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0001.jpeg"
image_negative_thumbnail_id_2="127"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0049.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="526"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
